Global Tumor Profiling Market Expected to Achieve 10% CAGR by 2029: Growth Forecast Insights

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Tumor Profiling Market Size By 2025?
The overall valuation of the tumor profiling sector has experienced substantial recent augmentation, projected to advance from its 2024 figure of $10.16 billion to reach $11.18 billion by 2025, reflecting a steady compound annual growth rate of 10.0%; this expansion across the past years is fundamentally linked to the mounting incidence of cancer diagnoses, the escalating need for tailored medical treatments, augmented spending in the healare domain, the wider implementation of companion diagnostic tools, and enhanced public consciousness regarding the benefits of detecting malignancies sooner.

How Big Is the Tumor Profiling Market Size Expected to Grow by 2029?
Anticipating substantial expansion, the tumor profiling market is projected for swift escalation over the foroming years, reaching a valuation of $16.37 billion by 2029, powered by a compound annual growth rate (CAGR) of 10.0%. This surge during the projection timeframe stems from several key factors, notably the increasing embrace of liquid biopsy methodologies, augmented financial commitment toward oncology investigation and development, the expanding demographic of older individuals, wider deployment of precision treatment approaches, alongside a greater volume of cooperative efforts in cancer research. Core developments set to define this period encompass a movement toward diagnostics that work in tandem with specific treatments, a greater frequency of testing multiple genes simultaneously, progress in next-generation sequencing technology, the incorporation of artificial intelligence into cancer identification processes, and ongoing improvements in tumor profiling tools.

View the full report here:
https://www.thebusinessresearchcompany.com/report/tumor-profiling-global-market-report

Which Key Market Drivers Powering Tumor Profiling Market Expansion and Growth?
Anticipated escalation in the need for bespoke medical treatments is projected to propel the expansion of the tumor profiling sector moving ahead. This tailored healare methodology, which customizes medical interventions based on singular patient attributes, is seeing increased acceptance as individuals pursue more exact therapeutic strategies promising superior results alongside reduced adverse reactions compared to conventional methods. Tumor profiling facilitates this individualized approach by pinpointing unique genetic alterations and biological indicators within a patient's neoplasm, thereby allowing for highly specific therapeutic interventions that minimize negative impacts. As an illustration, data released in February 2024 by the Personalized Medicine Coalition, an American entity focused on advancing tailored healare, indicated that personalized medications represented over thirty-three percent of all novel drug authorizations granted throughout 2023, sustaining this upward trajectory for a fourth successive year. Consequently, the intensifying desire for personalized medicine serves as a major impetus behind the augmentation observed in the tumor profiling market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24420&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Tumor Profiling Market?
Leading corporations within the tumor profiling sector are prioritizing the creation of sophisticated offerings, notably diagnostic tools augmented by artificial intelligence (AI), aiming to elevate both precision and speed in oncology care.AI embodies the application of sophisticated computational techniques for analyzing intricate datasets spanning genomics, proteomics, and clinical information, thereby facilitating quicker identification, tailored therapeutic approaches, and superior oversight of disease advancement.As an illustration, in the opening month of 2025, Panakeia Technologies LTD, a firm situated in the United Kingdom that concentrates on AI-based software for cancer identification and therapy, introduced PANProfiler Colon, a software application driven by AI expressly engineered to profile crucial molecular indicators like microsatellite instability (MSI) and mismatch repair deficiency (dMMR) directly from H and E stained visualizations of colon cancer tissues.This digital instrument allows for swift and precise molecular characterization of neoplasms, which is vital for confirming colorectal cancer diagnoses, pinpointing instances of Lynch syndrome, and guiding customized treatment plans.

What Are the Emerging Segments in the Tumor Profiling Market?
The tumor profilingmarket covered in this report is segmented -

1) By Technique: Genomics; Proteomics; Epigenetics; Metabolomics
2) By Technology: Sequencing Techniques; Quantitative Polymerase Chain Reaction (qPCR); Immunohistochemistry; In Situ Hybridization (ISH); Microarray
3) By Application: Personalized Cancer Medicine; Oncological Diagnostics; Research

Subsegments:
1) By Genomics: Next-Generation Sequencing (NGS); Polymerase Chain Reaction (PCR); Microarrays; Sanger sequencing
2) By Proteomics: Mass Spectrometry (MS); Protein Microarrays; Immunohistochemistry (IHC); Western Blotting
3) By Epigenetics: DNA Methylation Analysis; Chromatin Immunoprecipitation Sequencing (ChIP-seq); Histone Modification Profiling; Non-Coding RNA Analysis
4) By Metabolomics: Nuclear Magnetic Resonance (NMR) Spectroscopy; Gas Chromatography-Mass Spectrometry (GC-MS); Liquid Chromatography-Mass Spectrometry (LC-MS); Capillary Electrophoresis-Mass Spectrometry (CE-MS)

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24420&type=smp

Who Are the Global Leaders in the Tumor Profiling Market?
Major companies operating in the tumor profiling market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Hologic Inc., Illumina Inc., Sysmex Corporation, QIAGEN N.V., Exact Sciences Corporation, Guardant Health Inc., GenScript Biotech Corporation, NeoGenomics Inc., Caris Life Sciences Inc., Tempus Inc., Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Boreal Genomics Inc., Strand Life Sciences Pvt. Ltd., HTG Molecular Diagnostics Inc., Lucence Health Inc., Predictive Oncology Inc.

Which are the Top Profitable Regional Markets for the Tumor Profiling Industry?
North America was the largest region in the tumor profiling market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24420

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.